Joel Wedd, MD, MPH

Assistant Professor of Medicine

Department of Medicine

Phone: 404-778-4271

Fax: 404-778-2350



Dr. Wedd joined the Emory Liver Transplant Center in August 2014 after completing his gastroenterology and transplant hepatology fellowships at the University of Colorado. Originally from Virginia, he completed his MD and Masters of Public Health at the University of North Carolina and finished his residency in internal medicine at Beth Israel Deaconess Medical Center, a Harvard training hospital in Boston. Dr. Wedd’s clinical interests include end-stage liver disease, portal hypertension, and hepatocellular carcinoma. His research interest is improving our understanding of how to appropriately prioritize patients for liver transplantation.

Medical School: The University of North Carolina School of Medicine. Chapel Hill, NC
Masters of Public Health: The University of North Carolina Gillings School of Global Public Health. Chapel Hill, NC
Internship: Beth Israel Deaconess Medical Center. Boston, MA
Residency: Beth Israel Deaconess Medical Center. Boston, MA

American Board of Internal Medicine Certifications:
Internal Medicine, 2010


Specialties: Gastroenterology and Transplant Hepatology
Areas of Clinical Interest: End-stage liver disease; Portal hypertension; Hepatocellular carcinoma; and Liver transplantation


Honors and/or Awards:

2014 Freedman Award for Excellence in Academic Achievement, Clinical Abilities, and Leadership Skills. University of Colorado.
2012 Controversies in Transplantation Young Investigators Forum First place abstract presentation. Breckinridge, CO.
2011 Rocky Mountain Gut Club Mehta Award for excellence in the first year of gastroenterology fellowship. University of Colorado.
2003 Holderness Medical Fellowship. University of North Carolina.


Organizational Memberships
The American Association for the Study of Liver Disease
American College of Gastroenterology

Link to Emory Healthcare bio


* Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, Biggins SW. Stage of cirrhosis predicts risk of liver related death in low MELD patients with cirrhosis
awaiting liver transplant. Liver Transpl 2014 Jun. doi: 10.1002/lt.23929. [Epub ahead of print].

* Wedd J, Harper AM, Biggins SW. MELD Score, Allocation, and Distribution in the United States. Clinical Liver Disease. 2013 Aug: 2(4): 148-151.

* Smith JM, Biggins, SW, Haselby DG, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF,
Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK. Kidney, Pancreas, and Liver Allocation and Distribution in the United States. Am J of Transplant. 2012

* Wedd J, Biggins S. “Liver Retransplant in HCV”. Hepatitis C Virus and Liver Transplantation. Editor: Marina Berenguer. New York: Springer, 2014. Pages 95-106. Print.

* Wedd J, Biggins S. United States Liver Graft Allocation and Distribution. Invited review for the Educational Web Site of the International Liver Transplant Society and Liver
and Intensive Group of Europe. 2011.